Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Article Swipe
Lissete Sánchez‐Magraner
,
James Miles
,
Claire L. Baker
,
Christopher J. Applebee
,
Dae‐Jin Lee
,
Somaia Elsheikh
,
Shaimaa Lashin
,
Katriona Withers
,
Andrew G. Watts
,
Richard Parry
,
Christine Edmead
,
José I. López
,
Raj Kumar Mehta
,
Antoîne Italiano
,
Stephen G. Ward
,
Peter J. Parker
,
Banafshé Larijani
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22426576
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22426576
Supplementary Figures and Tables
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/0008-5472.22426576
- https://aacr.figshare.com/ndownloader/files/39872881
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361878006
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361878006Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/0008-5472.22426576Digital Object Identifier
- Title
-
Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 TreatmentWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Lissete Sánchez‐Magraner, James Miles, Claire L. Baker, Christopher J. Applebee, Dae‐Jin Lee, Somaia Elsheikh, Shaimaa Lashin, Katriona Withers, Andrew G. Watts, Richard Parry, Christine Edmead, José I. López, Raj Kumar Mehta, Antoîne Italiano, Stephen G. Ward, Peter J. Parker, Banafshé LarijaniList of authors in order
- Landing page
-
https://doi.org/10.1158/0008-5472.22426576Publisher landing page
- PDF URL
-
https://aacr.figshare.com/ndownloader/files/39872881Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/ndownloader/files/39872881Direct OA link when available
- Concepts
-
Selection (genetic algorithm), Sensitivity (control systems), PD-L1, Computer science, Medicine, Internal medicine, Artificial intelligence, Cancer, Immunotherapy, Engineering, Electronic engineeringTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361878006 |
|---|---|
| doi | https://doi.org/10.1158/0008-5472.22426576 |
| ids.doi | https://doi.org/10.1158/0008-5472.22426576 |
| ids.openalex | https://openalex.org/W4361878006 |
| fwci | 0.0 |
| type | preprint |
| title | Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9991000294685364 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T12334 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9908999800682068 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Lung Cancer Research Studies |
| topics[2].id | https://openalex.org/T12505 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9801999926567078 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Peptidase Inhibition and Analysis |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C81917197 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6303794384002686 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q628760 |
| concepts[0].display_name | Selection (genetic algorithm) |
| concepts[1].id | https://openalex.org/C21200559 |
| concepts[1].level | 2 |
| concepts[1].score | 0.585593044757843 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7451068 |
| concepts[1].display_name | Sensitivity (control systems) |
| concepts[2].id | https://openalex.org/C2781053074 |
| concepts[2].level | 4 |
| concepts[2].score | 0.5240980386734009 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q21100639 |
| concepts[2].display_name | PD-L1 |
| concepts[3].id | https://openalex.org/C41008148 |
| concepts[3].level | 0 |
| concepts[3].score | 0.39650487899780273 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[3].display_name | Computer science |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.31228625774383545 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.2611958384513855 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C154945302 |
| concepts[6].level | 1 |
| concepts[6].score | 0.1790820062160492 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11660 |
| concepts[6].display_name | Artificial intelligence |
| concepts[7].id | https://openalex.org/C121608353 |
| concepts[7].level | 2 |
| concepts[7].score | 0.12067559361457825 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[7].display_name | Cancer |
| concepts[8].id | https://openalex.org/C2777701055 |
| concepts[8].level | 3 |
| concepts[8].score | 0.10580885410308838 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[8].display_name | Immunotherapy |
| concepts[9].id | https://openalex.org/C127413603 |
| concepts[9].level | 0 |
| concepts[9].score | 0.0927024781703949 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[9].display_name | Engineering |
| concepts[10].id | https://openalex.org/C24326235 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q126095 |
| concepts[10].display_name | Electronic engineering |
| keywords[0].id | https://openalex.org/keywords/selection |
| keywords[0].score | 0.6303794384002686 |
| keywords[0].display_name | Selection (genetic algorithm) |
| keywords[1].id | https://openalex.org/keywords/sensitivity |
| keywords[1].score | 0.585593044757843 |
| keywords[1].display_name | Sensitivity (control systems) |
| keywords[2].id | https://openalex.org/keywords/pd-l1 |
| keywords[2].score | 0.5240980386734009 |
| keywords[2].display_name | PD-L1 |
| keywords[3].id | https://openalex.org/keywords/computer-science |
| keywords[3].score | 0.39650487899780273 |
| keywords[3].display_name | Computer science |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.31228625774383545 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.2611958384513855 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/artificial-intelligence |
| keywords[6].score | 0.1790820062160492 |
| keywords[6].display_name | Artificial intelligence |
| keywords[7].id | https://openalex.org/keywords/cancer |
| keywords[7].score | 0.12067559361457825 |
| keywords[7].display_name | Cancer |
| keywords[8].id | https://openalex.org/keywords/immunotherapy |
| keywords[8].score | 0.10580885410308838 |
| keywords[8].display_name | Immunotherapy |
| keywords[9].id | https://openalex.org/keywords/engineering |
| keywords[9].score | 0.0927024781703949 |
| keywords[9].display_name | Engineering |
| language | en |
| locations[0].id | doi:10.1158/0008-5472.22426576 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/ndownloader/files/39872881 |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/0008-5472.22426576 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5045235233 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9083-4284 |
| authorships[0].author.display_name | Lissete Sánchez‐Magraner |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Lissete Sánchez-Magraner |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5007256917 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3209-0410 |
| authorships[1].author.display_name | James Miles |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | James Miles |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5005753634 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Claire L. Baker |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Claire L. Baker |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5071516101 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6680-1404 |
| authorships[3].author.display_name | Christopher J. Applebee |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Christopher J. Applebee |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5078335965 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8995-8535 |
| authorships[4].author.display_name | Dae‐Jin Lee |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Dae-Jin Lee |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5109120324 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Somaia Elsheikh |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Somaia Elsheikh |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5020185567 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3541-5858 |
| authorships[6].author.display_name | Shaimaa Lashin |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Shaimaa Lashin |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5042872972 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Katriona Withers |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Katriona Withers |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5073900742 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4299-2717 |
| authorships[8].author.display_name | Andrew G. Watts |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Andrew G. Watts |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5078842859 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4572-4849 |
| authorships[9].author.display_name | Richard Parry |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Richard Parry |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5001353465 |
| authorships[10].author.orcid | https://orcid.org/0009-0004-7577-0509 |
| authorships[10].author.display_name | Christine Edmead |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Christine Edmead |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5044778496 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-0842-5348 |
| authorships[11].author.display_name | José I. López |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Jose Ignacio Lopez |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5101884586 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Raj Kumar Mehta |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Raj Mehta |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5060949051 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-8540-5351 |
| authorships[13].author.display_name | Antoîne Italiano |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Antoine Italiano |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5029868837 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-6795-6002 |
| authorships[14].author.display_name | Stephen G. Ward |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Stephen G. Ward |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5000996602 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-6218-2933 |
| authorships[15].author.display_name | Peter J. Parker |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Peter J. Parker |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5078343883 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-4735-1169 |
| authorships[16].author.display_name | Banafshé Larijani |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Banafshé Larijani |
| authorships[16].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/ndownloader/files/39872881 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9991000294685364 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W2586801360, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/0008-5472.22426576 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/ndownloader/files/39872881 |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/0008-5472.22426576 |
| primary_location.id | doi:10.1158/0008-5472.22426576 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/ndownloader/files/39872881 |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/0008-5472.22426576 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.and | 2 |
| abstract_inverted_index.Figures | 1 |
| abstract_inverted_index.Tables</p> | 3 |
| abstract_inverted_index.<p>Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 17 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.550000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.11316919 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |